Bionano Genomics Inc
BNGO
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.07M
Close$
$1.11
12% downside
Current Fair Value
12% downsideOvervalued by 12% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.07 Million |
|---|---|
| Enterprise Value | $8.52 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.85 |
| Beta | 1.62 |
| Outstanding Shares | 5,445,000 |
Return
| Return on Equity | -84.34% |
|---|---|
| Return on Assets | -48.76% |
| Return on Invested Capital | -93.40% |
Valuation & Multiples
| P/E Ratio | -0.21 |
|---|---|
| PEG | -0.13 |
| Price to Sales | 0.25 |
| Price to Book Ratio | 0.21 |
| Enterprise Value to Revenue | 0.3 |
| Enterprise Value to EBIT | -0.21 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 2.13 |
| Debt to Equity | 0.48 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$-0.81
Average shareholder expectationRevenue Estimate
$6.57 M
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-0.70
Average shareholder expectationRevenue Estimate
$7.48 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 15.99%▼ 0.59% |
|---|---|
| Total Invested | $1.02M▼ 24.83% |
| Investors Holding | 300% |
ESG Score
No data
About Bionano Genomics Inc
147 employees
CEO: R. Erik Holmlin